Registry for endocrine tumor surgery patients in Nancy
Part of Cancer, Hormones & metabolism clinical trials.
This study is a “registry,” meaning researchers collect health information from people who have surgery for certain hormone-related tumors. It may help doctors better understand outcomes and improve future care for endocrine tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery for an endocrine (hormone-related) tumor at University Nancy Brabois Hospital
- You can understand the study information clearly
- You are willing to sign the consent form
- You agree to have your medical and treatment details recorded for the registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a research registry that collects information from people with aggressive pituitary tumors. It may help researchers better understand these tumors by building a large, shared dataset over time.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This study is creating a registry (a database) to gather information about people with spinal tumors who are undergoing surgery. By joining, you help doctors better understand these tumors and improve future treatments.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
This is a hospital-based study that builds a clinical and biological database for people treated for rectal cancer at the Montpellier Cancer Institute. It helps researchers organize health information to better understand rectal cancer and improve future care.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
Hear when a new Endocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.